Abstract:Tauopathies, synucleinopathies, Aβ amyloidosis, TDP-43 proteinopathies, and prion diseases- these neurodegenerative diseases have in common the formation of amyloid filaments rich in cross-β sheets. Cryo-electron microscopy now permits the visualization of amyloid assemblies at atomic resolution, ushering a wide range of structural studies on several of these poorly understood amyloidogenic proteins. Amyloids are polymorphic with minor modulations in reaction environment affecting the overall architecture of their assembly, making amyloids an extremely challenging venture for structure-based therapeutic intervention. In 2017, the first cryo-EM structure of tau filaments from an Alzheimer's disease-affected brain established that in vitro assemblies might not necessarily reflect the native amyloid fold. Since then, brain-derived amyloid structures for several proteins across many neurodegenerative diseases have uncovered the disease-relevant amyloid folds. It has now been shown for tauopathies, synucleinopathies and TDP-43 proteinopathies, that distinct amyloid folds of the same protein might be related to different diseases. Salient features of each of these brain-derived folds are discussed in detail. It was also recently observed that seeded aggregation does not necessarily replicate the brain-derived structural fold. Owing to high throughput structure determination, some of these native amyloid folds have also been successfully replicated in vitro. In vitro replication of disease-relevant filaments will aid development of imaging ligands and defibrillating drugs. Towards this direction, recent high-resolution structures of tau filaments with positron emission tomography tracers and a defibrillating drug are also discussed. This review summarizes and celebrates the recent advancements in structural understanding of neuropathological amyloid filaments using cryo-EM.

Cryo‐electron Microscopy Imaging of Alzheimer's Amyloid‐beta 42 Oligomer Displayed on a Functionally and Structurally Relevant Scaffold

Structural architecture of amyloid-β oligomers, curvilinear protofibrils and annular assemblies, imaged by cryo-EM and cryo-ET

Cryo-EM structures of amyloid-β 42 filaments from human brains

Identification of a Novel Parallel Β‐strand Conformation Within Molecular Monolayer of Amyloid Peptide

Fibril structure of amyloid-β(1–42) by cryo–electron microscopy

Alzheimer Aβ Amyloid Annular Fibrils: Insight into Polymorphism

Cryo-EM structures of lipidic fibrils of amyloid-β (1-40)

Energy Landscapes of the Monomer and Dimer of the Alzheimer’s Peptide Aβ(1–28)

Morphology and Structural Dynamics of Amyloid Beta 42 Assembly in Vitro

Cryo-EM structure and polymorphism of Aβ amyloid fibrils purified from Alzheimer’s brain tissue

Hollow core of Alzheimer's Abeta42 amyloid observed by cryoEM is relevant at physiological pH.

Crystal structure of the amyloid-β p3 fragment provides a model for oligomer formation in Alzheimer's disease

Toxic fibrillar oligomers of amyloid-β have cross-β structure

Amyloid β 42 fibril structure based on small-angle scattering

Nanopore analysis of β-amyloid peptide aggregation transition induced by small molecules.

CryoET of β-amyloid and tau within postmortem Alzheimer's disease brain

Study of biologic characters of Aβ42 and Aβ42 oligomer

Single molecule study of initial structural features on the amyloidosis process.

Real-time monitoring of the amyloid β1-42 monomer-to-oligomer channel transition using a lipid bilayer system

Aβ(1–42) Fibril Structure Illuminates Self-Recognition and Replication of Amyloid in Alzheimer's Disease

Emerging Trends in Cryo-EM-based Structural Studies of Neuropathological Amyloids